Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [(111)In]-labeled CHX-A″DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines.
about
Theragnostic ultrasound using microbubbles in the treatment of prostate cancerUltrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.A nuclear chocolate box: the periodic table of nuclear medicine.Imaging of HER2 may improve the outcome of external irradiation therapy for prostate cancer patients.Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy.
P2860
Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [(111)In]-labeled CHX-A″DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Imaging agents for in vivo mol ...... ncer: Cellular processing of [
@nl
Imaging agents for in vivo mol ...... in prostate cancer cell lines.
@en
type
label
Imaging agents for in vivo mol ...... ncer: Cellular processing of [
@nl
Imaging agents for in vivo mol ...... in prostate cancer cell lines.
@en
prefLabel
Imaging agents for in vivo mol ...... ncer: Cellular processing of [
@nl
Imaging agents for in vivo mol ...... in prostate cancer cell lines.
@en
P2860
P356
P1476
Imaging agents for in vivo mol ...... in prostate cancer cell lines.
@en
P2093
Anna Orlova
Jennie Malmberg
P2860
P304
P356
10.3892/ETM.2011.217
P577
2011-02-22T00:00:00Z